Carmen Plasencia

631 total citations
12 papers, 547 citations indexed

About

Carmen Plasencia is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Carmen Plasencia has authored 12 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Carmen Plasencia's work include Bioactive Compounds and Antitumor Agents (3 papers), Genetic factors in colorectal cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Carmen Plasencia is often cited by papers focused on Bioactive Compounds and Antitumor Agents (3 papers), Genetic factors in colorectal cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Carmen Plasencia collaborates with scholars based in United States, Spain and Italy. Carmen Plasencia's co-authors include Nouri Neamati, Yingping Hou, Xiaohong Chen, Albert Abad, Eva Martinez‐Balibrea, Anna Martínez‐Cardús, Nouri Neamati, David I. Quinn, José Luís Zamora Manzano and Eva Musulén and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Cancer and Molecular Cancer Therapeutics.

In The Last Decade

Carmen Plasencia

12 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Plasencia United States 9 313 227 88 81 76 12 547
Suzanne J. Bakewell United States 10 184 0.6× 282 1.2× 94 1.1× 45 0.6× 34 0.4× 19 520
Li Ding China 15 434 1.4× 242 1.1× 139 1.6× 129 1.6× 44 0.6× 38 877
Kathleen Mosure United States 8 274 0.9× 385 1.7× 79 0.9× 50 0.6× 77 1.0× 10 729
René Nieves-Alicea United States 12 346 1.1× 109 0.5× 19 0.2× 85 1.0× 57 0.8× 15 565
Peyman Obeidy Australia 11 206 0.7× 186 0.8× 67 0.8× 23 0.3× 25 0.3× 19 607
Stefan R. Vink Netherlands 11 485 1.5× 103 0.5× 72 0.8× 65 0.8× 33 0.4× 13 618
Е. В. Степанова Russia 17 506 1.6× 165 0.7× 45 0.5× 175 2.2× 44 0.6× 59 803
Dixy E. Green United States 16 430 1.4× 57 0.3× 188 2.1× 80 1.0× 44 0.6× 27 659
Patricia Juárez Mexico 13 298 1.0× 251 1.1× 22 0.3× 99 1.2× 67 0.9× 26 718
Magdalena Rudzińska Poland 15 294 0.9× 123 0.5× 22 0.3× 121 1.5× 114 1.5× 26 602

Countries citing papers authored by Carmen Plasencia

Since Specialization
Citations

This map shows the geographic impact of Carmen Plasencia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Plasencia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Plasencia more than expected).

Fields of papers citing papers by Carmen Plasencia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Plasencia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Plasencia. The network helps show where Carmen Plasencia may publish in the future.

Co-authorship network of co-authors of Carmen Plasencia

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Plasencia. A scholar is included among the top collaborators of Carmen Plasencia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Plasencia. Carmen Plasencia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Eva Musulén, et al.. (2009). Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy. International Journal of Cancer. 124(12). 2905–2910. 60 indexed citations
2.
Cao, Xuefei, Carmen Plasencia, Atsuko Kanzaki, et al.. (2009). Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis. Current Cancer Drug Targets. 9(2). 189–201. 6 indexed citations
3.
Plasencia, Carmen, Fedora Grande, Takashi Oshima, et al.. (2009). Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity. Cancer Biology & Therapy. 8(5). 458–465. 19 indexed citations
4.
Martinez‐Balibrea, Eva, Carmen Plasencia, Alba Ginés, et al.. (2009). A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines. Molecular Cancer Therapeutics. 8(4). 771–778. 56 indexed citations
5.
Plasencia, Carmen, Eva Martinez‐Balibrea, Anna Martínez‐Cardús, et al.. (2006). Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. International Journal of Oncology. 29(1). 225–35. 63 indexed citations
6.
Plasencia, Carmen, Raveendra Dayam, Qingcai Wang, et al.. (2005). Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines. Molecular Cancer Therapeutics. 4(7). 1105–1113. 29 indexed citations
7.
Plasencia, Carmen, et al.. (2005). Synthesis and Biological Evaluation of Dimeric RGD Peptide−Paclitaxel Conjugate as a Model for Integrin-Targeted Drug Delivery.. Journal of Medicinal Chemistry. 48(18). 5874–5874. 7 indexed citations
8.
Chen, Xiaohong, Carmen Plasencia, Yingping Hou, & Nouri Neamati. (2005). Synthesis and Biological Evaluation of Dimeric RGD Peptide−Paclitaxel Conjugate as a Model for Integrin-Targeted Drug Delivery. Journal of Medicinal Chemistry. 48(4). 1098–1106. 221 indexed citations
9.
Plasencia, Carmen, Albert Abad, Eva Martinez‐Balibrea, & Miquel Tarón. (2004). Antiproliferative effects of ZD0473 (AMD473) in combination with 5-Fluorouracil or SN38 in human colorectal cancer cell lines. Investigational New Drugs. 22(4). 399–409. 8 indexed citations
10.
Sechi, Mario, Roberto Dallocchio, Alessandro Dessì, et al.. (2004). Design and Synthesis of Novel Dihydroxyindole-2-Carboxylic Acids as HIV-1 Integrase Inhibitors. Antiviral chemistry & chemotherapy. 15(2). 67–81. 28 indexed citations
11.
Plasencia, Carmen, Patrick H. Rooney, Miquel Tarón, et al.. (2003). Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: Implications in the analysis of 5FU-acquired resistance mechanisms. International Journal of Oncology. 22(5). 945–53. 13 indexed citations
12.
Plasencia, Carmen, et al.. (2000). Cytotoxic Effects of Topotecan Combined with Various Active G2/M-Phase Anticancer Drugs in Human Tumor-Derived Cell Lines. Investigational New Drugs. 18(2). 139–148. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026